ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SAN Sanofi

87.70
-1.15 (-1.29%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sanofi SAN Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-1.15 -1.29% 87.70 11:40:00
Open Price Low Price High Price Close Price Prev Close
89.06 87.45 89.65 87.70 88.85
more quote information »

Recent News

Date Time Source Heading
4/23/202401:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
4/17/202401:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
4/12/202414:05GLOBESanofi: Information concerning the total number of voting..
4/08/202412:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
3/22/202402:30GLOBECommuniqué de presse : Mise en ligne du document «Q1 2024..
3/15/202415:04GLOBESanofi: Information concerning the total number of voting..
3/11/202402:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
2/24/202409:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
2/23/202412:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
2/23/202401:00GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
2/22/202413:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
2/20/202417:40GLOBESanofi: Information concerning the total number of voting..
2/16/202401:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
2/15/202408:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
2/05/202402:00GLOBECommuniqué de presse : Entraide, conditions de travail..
2/01/202401:30GLOBECommuniqué de presse : François-Xavier Roger nommé Directeur..
1/25/202414:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
1/23/202406:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202401:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
1/17/202416:57GLOBESanofi: Informations relatives au nombre de droits de vote..
1/09/202402:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
1/09/202401:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
12/21/202302:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
12/21/202301:30GLOBEPress Release: Sanofi announces end of program evaluating..
12/19/202307:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
12/18/202315:59GLOBESanofi: Informations relatives au nombre de droits de vote..
12/15/202301:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
12/15/202301:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/11/202317:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
12/11/202316:08GLOBEPress Release: Statement on FTC challenge to proposed..
12/11/202301:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
12/10/202319:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
12/07/202302:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
12/07/202302:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
12/07/202301:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
12/06/202321:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
12/06/202308:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
12/06/202305:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
11/30/202309:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
11/27/202310:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
11/27/202302:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
11/27/202301:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
11/23/202312:00GLOBESanofi: Information concerning the total number of voting..
11/07/202308:56DJNSanofi Under Preliminary Probe in France Over Possible..
10/30/202308:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
10/27/202311:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
10/27/202304:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
10/27/202302:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
10/27/202302:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
10/27/202302:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business

Your Recent History

Delayed Upgrade Clock